We discussed two cases of symptomatic female carriers to Duchenne Muscular Dystrophy. The first case is a 20 year-old girl with classical phenotypic manifestation of the disease, similar to the condition in boys. The case 2 is a 62 year-old woman with progressive muscular weakness. The disease is much less common in woman than men so both cases described here are considered rare forms of the disease, with several clinical implications. In both cases, a progressive muscle weakness, impairment in walking and sleeping was observed, in addition to obstructive sleep apnea syndrome and alveolar hypoventilation, that required noninvasive ventilatory support.
Some early symptoms might include not walking as soon as other babies, not standing up when other babies typically stand, walking with a waddle, trouble going Can women exhibit duchenne muscular dystrophy stairs, or difficulty running and jumping. By contrast, the male DMD patient exhibited almost no expression of dystrophin in the muscle fiber membrane. Exhibir can be passed from parent to childor it can be the result of random spontaneous genetic mutations, which may occur during any pregnancy. Muscle Nerve. Journal List Sleep Sci v. Lack of dystrophin causes muscle damage and progressive weakness, beginning in early childhood. Females, on the other hand, have two copies of the X chromosomes. Case report 2. In total, 31 cases carried deletion mutations, while 10 carried duplication mutations. Its content is solely the City of spokane water heater code of the authors and does not necessarily represent the official views of Stanford University or the Department of Genetics.
Gay day orlando. Looking for more information, support or ways to get involved?
You May Be Interested In. Duchenne muscular dystrophy, which represents about half of all cases of muscular dystrophy, affects about one in 5, males at birth. Psychological stress affects both mental and physical health. Muscular dystrophy MD is Latigo saddle straps group of muscle diseases that results in increasing weakening Can women exhibit duchenne muscular dystrophy breakdown of skeletal muscles over time. In addition, due to a process called X-inactivationin rare cases, female carriers Ashton kutcher nudes have mild, moderate, or severe DMD. FDA grants accelerated approval to first drug for Duchenne muscular dystrophy. Depression and cardiac mortality: results from a community-based longitudinal study. If a woman tests positive for DMD or BMD, she should be referred to a cardiologist and will need to be carefully monitored during a pregnancy and throughout the rest of her life. Cardiomyopathy is a common cause of morbidity and mortality in BMD, with the mean age of death being in the mids 9. Limb-girdle muscular dystrophy 1 Oculopharyngeal Facioscapulohumeral Myotonic Distal most. Sertraline treatment of major depression in patients with acute MI or unstable angina. Hypokalemic Thyrotoxic Hyperkalemic. Am J Hum Genet. Speech delay.
Because the mutation for Duchenne is found on the X chromosome, only females can be carriers for the mutation on the gene that encodes for dystrophin protein.
- Duchenne Muscular Dystrophy DMD , an X-linked condition, is the most common muscular dystrophy in children 1 and affects families of all ethnicities.
- Muscular dystrophy MD is a group of muscle diseases that results in increasing weakening and breakdown of skeletal muscles over time.
- Although DMD is considered the most common fatal inherited disorder that is diagnosed in childhood, many parents know little or nothing about this disease.
- Chat or rant, adult content, spam, insulting other members, show more.
Two of my baby brothers have Duchenne muscular dystrophy, my mother is a carrier. My question is if I am a carrier would I get symptoms as I age? And what are the chances of me being a carrier? These are great questions! Typically, carriers for DMD do not have any problems.
Duchenne muscular dystrophy is caused by a change in a gene called DMD. This is where the wording can get confusing! The DMD gene makes an important muscle protein, called Dystrophin. Without Dystrophin, the muscles will get weaker and weaker over time. This causes the symptoms that you see in patients with muscular dystrophy. As long as you have one working version of the DMD gene, your muscles will have enough dystrophin to work.
This makes muscular dystrophy a recessive disease. More specifically, DMD is an X-linked recessive disease. This means the DMD gene is located on the X chromosome. Girls have two X chromosomes: one from Mom and one from Dad. This means they have two copies of the DMD gene.
And since muscular dystrophy is recessive, as long as the girl has at least one working version of the gene she will be fine. But boys only have one X chromosome, inherited from Mom. They inherit a Y chromosome from Dad! This means that boys only have one copy of the DMD gene.
Symptoms start to appear when they are between 16 months and 8 years old. Some early symptoms might include not walking as soon as other babies, not standing up when other babies typically stand, walking with a waddle, trouble going up stairs, or difficulty running and jumping. Because muscles of children with DMD get weaker over time, eventually these children will start using a wheelchair. Boys who have DMD tend to live shorter lives than the average person. Boys who inherit one broken DMD gene will develop muscular dystrophy, while girls who inherit one broken gene will be carriers.
Image modified from Wikimedia. Since your mom is a carrier, she could have passed either X chromosome to you: the one with the broken DMD gene or the one with the working DMD gene. Although girls who carry one copy of this broken DMD gene typically do not show symptoms, they do sometimes have problems:. Generally speaking, more research needs to be done to better understand how best to take care of carriers of Duchenne muscular dystrophy.
I am sure they would be happy to help! X-inactivation, and how carriers of X-linked disease can sometimes show mild symptoms. The Tech Interactive S. Market St. San Jose, CA Federal ID Its content is solely the responsibility of the authors and does not necessarily represent the official views of Stanford University or the Department of Genetics.
Teaching Resources. Abnormal heart rate Heart rhythm disorders Irregular heart beat Irregular heartbeat [ more ]. Speech and language difficulties. Tips for the Undiagnosed. Dystrophin is part of a complex structure involving several other protein components.
Can women exhibit duchenne muscular dystrophy. The Duchenne Muscular Dystrophy (Dystrophin) Gene
Clinical and Genetic Characterization of Female Dystrophinopathy
Duchenne muscular dystrophy DMD is a rapidly progressive form of muscular dystrophy caused by a mutation in the DMD gene. DMD is a rapidly progressive form of muscular dystrophy that occurs primarily in boys.
It is caused by an alteration mutation in a gene, called the DMD gene that can be inherited in families in an X-linked recessive fashion, but it often occurs in people from families without a known family history of the condition. Individuals who have DMD have progressive loss of muscle function and weakness, which begins in the lower limbs.
The DMD gene is the second largest gene to date, which encodes the muscle protein, dystrophin. Boys with Duchenne muscular dystrophy do not make the dystrophin protein in their muscles. Duchenne muscular dystrophy affects approximately 1 in male births worldwide.
Because this is an inherited disorder, risks include a family history of Duchenne muscular dystrophy. The symptoms usually appear before age 6 and may appear as early as infancy. Typically, the first noticeable symptom is delay of motor milestones, including sitting and standing independently. The mean age for walking in boys with Duchenne muscular dystrophy is 18 months. There is progressive muscle weakness of the legs and pelvic muscles, which is associated with a loss of muscle mass wasting.
This muscle weakness causes a waddling gait and difficulty climbing stairs. Muscle weakness also occurs in the arms, neck, and other areas, but not as severely or as early as in the lower half of the body. Calf muscles initially enlarge and the enlarged muscle tissue is eventually replaced with fat and connective tissue pseudohypertrophy. Muscle contractures occur in the legs, making the muscles unusable because the muscle fibers shorten and fibrosis occurs in connective tissue.
Occasionally, there can be pain in the calves. Symptoms usually appear in boys aged 1 to 6. There is a steady decline in muscle strength between the ages of 6 and 11 years. By age 10, braces may be required for walking, and by age 12, most boys are confined to a wheelchair. Bones develop abnormally, causing skeletal deformities of the spine and other areas. Muscular weakness and skeletal deformities frequently contribute to breathing disorders. Cardiomyopathy enlarged heart occurs in almost all cases, beginning in the early teens in some, and in all after the age of 18 years.
Intellectual impairment may occur, but it is not inevitable and does not worsen as the disorder progresses. Few individuals with DMD live beyond their 30s.
Breathing complications and cardiomyopathy are common causes of death. Duchenne muscular dystrophy is diagnosed in several ways. A clinical diagnosis may be made when a boy has progressive symmetrical muscle weakness. The symptoms present before age 5 years, and they often have extremely elevated creatine kinase blood levels which are described below.
If untreated, the affected boys become wheelchair dependent before age 13 years. A muscle biopsy taking a sample of muscle for dystrophin studies can be done to look for abnormal levels of dystrophin in the muscle. The dystrophin protein can be visualized by staining the muscle sample with a special dye that allows you to see the dystrophin protein. A muscle which has average amounts of dystrophin will appear with the staining technique as though there is caulking around the individual muscles cells and it is holding them together like window panes.
A boy with Duchenne, on the other hand, will have an absence of dystrophin and appear to have an absence of the caulking around the muscle cells. Some individuals can be found to have an intermediate amount of the dystrophin protein. Often these boys are classified as having Becker muscular dystrophy. Genetic testing looking at the body's genetic instructions on a blood sample for changes in the DMD gene can help establish the diagnosis of Duchenne muscular dystrophy without performing a muscle biopsy.
Those individuals who are not found to have a detected change in the DMD gene using this method, and who are diagnosed with DMD by biopsy, still have a change in their gene but it is in areas of the gene that are not examined using these methods. However, the results of genetic testing may not be conclusive of a diagnosis of DMD, and only the muscle biopsy can tell the level of dystrophin protein for sure.
For the remaining individuals, a combination of clinical findings, family history, blood creatine kinase concentration and muscle biopsy with dystrophin studies confirms the diagnosis. Creatine kinase is an enzyme that is present normally in high concentrations in the muscle cells of our body. During the process of muscle degeneration or breakdown, the muscle cells are broken open and their contents find their way to the bloodstream. Therefore elevated levels of creatine kinase can be detected from a blood test and it is a measure of muscle damage.
Elevated levels can be the result of multiple reasons including acute muscle injury, or chronic condition such as Duchenne muscular dystrophy. Treatment for Duchenne muscular dystrophy is aimed at the symptoms. Aggressive management of dilated cardiomyopathy with anti-congestive medications is used, including cardiac transplantation in severe cases. Assistive devices for respiratory complications may be needed, especially at night.
The medication prednisone - a steroid - is given to improve the strength and function of individuals with DMD. Prednisone has been shown to prolong the ability to walk by 2 to 5 years. However, the possible side effects of prednisone include weight gain, high blood pressure, behavior changes, and delayed growth.
A synthetic form of prednisilone, called Deflazacort, is used in Europe and believed to have fewer side effects than prednisone. A medication called cyclosporine has been used and has improved clinical function in children, but its use is controversial due to cyclosporine-induced myopathy.
Oxandrolone, a medication used in a research study, has similar effects to prednisone with fewer side effects. Several other therapies are also under investigation, including coenzyme Q10, glutamine, pentoxifylline, and PTC see clinical research below. Physical therapy is used to promote mobility and prevent contractures. Surgery may be needed for severe contractures and scoliosis. Duchenne muscular dystrophy is inherited in an X-linked recessive pattern. Males have only one copy of the X chromosome from their mother and one copy of the Y chromosome from their father.
Females, on the other hand, have two copies of the X chromosomes.. Since females have two copies of this gene, if one copy does not work, they have a second back up copy to produce the dystrophin protein.
A woman who has a genetic change in one of her two copies is said to be "a carrier" of Duchenne muscular dystrophy. Carriers do not have Duchenne muscular dystrophy and most are unaware that they even carry this change in their genetic material unless they have a family history.
However, recent studies have shown that some carrier females approximately 20 percent will show symptoms of DMD, including muscle weakness and cardiac abnormalities.
With an X-linked recessive condition, the chance of passing on the changed non-working copy of the gene to a child is different for males and females. Females who carry the changed copy of the gene have a 50 percent chance of passing it on with each pregnancy.
Thus, there is a 25 percent chance of having a affected child with DMD eg. However, in the remaining third of individuals with DMD, the change in the dystrophin gene is a new genetic change, or de novo change and about 10 percent of new mutations are due to gonadal mosaicism.
Gonadal mosaicism refers to a condition where an individual has two or more cell populations that differ in genetic makeup in their eggs or sperm. If a male with DMD were to have children, all of his daughters would be carriers and none of his sons would be affected. Currently various reproductive options are available to families. The preconception options include MicroSort which is a technology that can separate sperm containing X chromosomes allowing for an increase in chances of having a female.
The second reproductive option is preimplantation genetic diagnosis PGD , which is a technique that can allow the cells of a fertilized egg to be tested to determine if it contains a change in the DMD gene and then implant those eggs which do not. The post conception options include Chorionic Villus Sampling CVS and amniocentesis which analyze sampled cells derived from the developing fetus. Several of the prenatal testing options for pregnancies at increased risk are available when the DMD disease-causing mutation has been identified in a family member, or if informative, genetically-linked markers have been identified.
Duchenne and Becker muscular dystrophy. Finding Reliable Health Information Online. About Duchenne Muscular Dystrophy. What is Duchenne muscular dystrophy? What are the symptoms of Duchenne muscular dystrophy? How is Duchenne muscular dystrophy diagnosed? What is the treatment for Duchenne muscular dystrophy? Is Duchenne muscular dystrophy inherited? Last updated: April 18,